GLORIA PHARMA.(SZ:002437) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-21 10:42Core Viewpoint - The company, Harbin Yuheng Pharmaceutical Co., Ltd., has achieved the conditions for the first lock-up period release of its 2024 restricted stock incentive plan, allowing 40 eligible participants to unlock a total of 3,872,000 shares, which represents approximately 0.1724% of the company's total share capital [2][10]. Summary by Sections Incentive Plan Details - The first lock-up period for the reserved grant of the 2024 restricted stock incentive plan has been fulfilled, with the release date set for October 22, 2025 [3][16]. - The company completed the approval process for the incentive plan, including board and shareholder meetings, from January to March 2024 [4][5]. Stock Grant and Repurchase - The company granted a total of 72,391,000 shares of restricted stock to 105 participants on March 12, 2024, and has conducted repurchases of shares from departing employees [5][8]. - As of October 10, 2024, the company completed the registration of 10,180,000 shares for reserved grants to 43 participants [8]. Lock-up Release Conditions - The conditions for the release of the restricted stock include meeting specific performance criteria as outlined in the incentive plan [13]. - The first lock-up period for the reserved grant shares ended on October 10, 2025, allowing for the release of shares [13]. Share Structure Changes - The release of the restricted shares will result in changes to the company's share structure, with the total number of shares released being 3,872,000, which is 40% of the total reserved grant shares [16]. - The final changes to the share structure will be confirmed based on the registration data from the China Securities Depository and Clearing Corporation [16].